GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Price-to-Owner-Earnings

LSL Pharma Group (TSXV:LSL) Price-to-Owner-Earnings : (As of Jun. 20, 2024)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Price-to-Owner-Earnings?

As of today (2024-06-20), LSL Pharma Group's share price is C$0.48. LSL Pharma Group does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for LSL Pharma Group's Price-to-Owner-Earnings or its related term are showing as below:


TSXV:LSL's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.615
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-20), LSL Pharma Group's share price is C$0.48. LSL Pharma Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.06. Therefore, LSL Pharma Group's PE Ratio for today is At Loss.

As of today (2024-06-20), LSL Pharma Group's share price is C$0.48. LSL Pharma Group's EPS without NRI for the trailing twelve months (TTM) ended in was C$-0.06. Therefore, LSL Pharma Group's PE Ratio without NRI for today is At Loss.


LSL Pharma Group Price-to-Owner-Earnings Historical Data

The historical data trend for LSL Pharma Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Price-to-Owner-Earnings Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - -

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of LSL Pharma Group's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LSL Pharma Group's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Price-to-Owner-Earnings falls into.



LSL Pharma Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

LSL Pharma Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.48/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LSL Pharma Group  (TSXV:LSL) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


LSL Pharma Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


LSL Pharma Group (TSXV:LSL) Business Description

Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines